“Acknowledging these problems is not a concession to prohibition. Solving them is how we protect the future of cannabis access.”
By Steph Sherer, Americans for Safe Access
For much of the modern cannabis movement, raising concerns about safety has been politically complicated. Advocates have spent decades fighting exaggerated claims about cannabis harms, and opponents have been eager to turn every adverse event, regulatory failure or unanswered scientific question into an argument for prohibition.
That history created an understandable reflex: When someone raises a cannabis safety concern, defend cannabis. It also helps explain why cannabis policy debates often center on two opposing narratives. One side presents cannabis as uniquely dangerous and promotes prohibition or restriction as the answer. The other minimizes legitimate concerns out of fear of giving opponents ammunition.
Historically, medical cannabis policy has advanced by addressing public concerns. We have developed product-safety standards, improved patient and professional education, challenged government misinformation with evidence—including forcing the Drug Enforcement Administration (DEA) to remove the “gateway drug” theory and other unsupported assertions from its materials—and fought to remove research barriers. Entrepreneurs have also built cannabis-specific infrastructure where traditional systems did not exist, from specialized laboratories and manufacturing equipment to services designed for
Read full article on Marijuana Moment
